SEC Form 5 · accession 0001209191-15-013751
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryuji Ueno
10% Owner
Period of report
Dec 31, 2014
Accepted (ET)
Feb 13, 2015 · 5:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Dec 29, 2014 | G | 1,000,000 | $0.00 | D | 21,460,802 | I | By S&R Technology Holdings, LLC |
| Class A Common Stock | holding | — | — | — | 353,530 | D | ||
| Class A Common StockF2 | holding | — | — | — | 60,357 | I | By Wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F2Dr. Ueno disclaims beneficial ownership of the reported securities.